Skip to the content
Home
EmployerHealth planPublic sectorBrokers & consultantsProviderLife sciences
--------------
Sharecare+: AdvocacyCareLinx: Home careDigital therapeuticsSmart OmixHealth security
Community Well-Being IndexWell-Being ConnectBlue Zones Project
Find a doctorFind a caregiverAskMDSharecare Windows
Features:
Vital Voices
Condition Headquarters:
Your guide to managing depressionUnderstanding and treating thyroid eye diseaseA patient’s guide to Graves' diseaseUnderstanding and treating Crohn’s diseaseYou are more than atopic dermatitisUnderstanding your treatment options for MSYour guide to managing wet age-related macular degenerationA patient’s guide to managing ankylosing spondylitisManaging and slowing the progression of psoriatic arthritisBack to school pediatric ADHD headquartersTaking control of type 2 diabetesView All
Alzheimer's diseaseMental healthAsthmaMigrainesBreast cancerMultiple sclerosisCancerParkinson's diseaseCoronavirusPsoriasisCrohn's diseaseRheumatoid arthritisDiet and nutritionSexual healthDigestive healthSkin healthExercise and fitnessSleep disordersHeart healthTransgender healthHepatitis CType 2 diabetesInflammationVaccinations and immunizationsLung cancerWeight managementMacular degenerationWomen's healthMen's healthView All
About SharecareLeadershipEditorial policyBlogPress centerHealth equityInvestor relationsContact us
EmployerHealth planPublic sectorBrokers & consultantsProviderLife sciences
--------------
Sharecare+: AdvocacyCareLinx: Home careDigital therapeuticsSmart OmixHealth security
Community Well-Being IndexWell-Being ConnectBlue Zones Project
Health Tools
Find a doctorFind a caregiverAskMDSharecare Windows
Condition Education Centers
View All
Features:
Vital Voices
Condition Headquarters:
Your guide to managing depressionUnderstanding and treating thyroid eye diseaseA patient’s guide to Graves' diseaseUnderstanding and treating Crohn’s diseaseYou are more than atopic dermatitisUnderstanding your treatment options for MSYour guide to managing wet age-related macular degenerationA patient’s guide to managing ankylosing spondylitisManaging and slowing the progression of psoriatic arthritisBack to school pediatric ADHD headquartersTaking control of type 2 diabetesView All
Health Topics
View All
Alzheimer's diseaseMental healthAsthmaMigrainesBreast cancerMultiple sclerosisCancerParkinson's diseaseCoronavirusPsoriasisCrohn's diseaseRheumatoid arthritisDiet and nutritionSexual healthDigestive healthSkin healthExercise and fitnessSleep disordersHeart healthTransgender healthHepatitis CType 2 diabetesInflammationVaccinations and immunizationsLung cancerWeight managementMacular degenerationWomen's healthMen's healthView All
About SharecareLeadershipEditorial policyBlogPress centerHealth equityInvestor relationsContact us
  • About Sharecare
  • Leadership
  • Editorial Policy
  • Blog
  • Press Center
  • Health Equity
  • Investor Relations
  • Contact Us
Back to In The News

Clinical trial platform Science 37 is going public via a SPAC merger

Author:
Riley Brands
Share:

©2023 Sharecare, Inc.

AdChoicesCookiesYour Privacy ChoicesPrivacyTerms
About Sharecare
About SharecareLeadershipEditorial policyBlogPress centerHealth equityInvestor relationsCareersContact usHelpSitemap
Health Topics
Breast cancerCoronavirusCrohn's diseaseHeart healthHepatitis CMigrainesPsoriasisRheumatoid arthritisType 2 diabetesWomen's healthView all